CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 397 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $621 | -58.4% | 13,676 | -48.6% | 0.06% | -45.6% |
| Q2 2023 | $1,492 | -99.8% | 26,583 | +93.0% | 0.11% | +39.0% |
| Q3 2022 | $900,000 | -73.7% | 13,777 | -75.5% | 0.08% | -71.8% |
| Q2 2022 | $3,422,000 | +143.4% | 56,311 | +151.4% | 0.29% | +179.8% |
| Q1 2022 | $1,406,000 | +70.6% | 22,401 | +106.0% | 0.10% | +23.8% |
| Q4 2021 | $824,000 | -67.8% | 10,876 | -48.2% | 0.08% | -53.6% |
| Q1 2021 | $2,559,000 | +944.5% | 21,000 | +292.4% | 0.18% | +1292.3% |
| Q1 2018 | $245,000 | – | 5,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |